Denton Pharma, Inc. recalls Ranitidine Tablets, USP 150 mg , a). 4 count bottle (NDC 70934-017-04), b). 20-count bottle (NDC 70934-017-20), c).
Denton Pharma recalls 150mg ranitidine tablets with NDMA impurity detected. Products sold between 2021-2022 may pose health risks. Consumers should check product labels and contact manufacturer.
Lower-risk recall
CGMP Deviations: Presence of NDMA impurity detected in product.
Contact the company & request your remedy
What happened, in plain English
Denton Pharma is recalling certain ranitidine tablets due to the presence of NDMA impurity, a potential carcinogen. This recall affects specific bottle sizes and expiration dates sold between 2021 and 2022. The impurity could pose health risks with long-term use, so affected consumers should stop using these products. Read more at govinfonow.com/recall/37510-denton-pharma-ranitidine-tablets-150mg-recall-ndma-impurity-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/37510-denton-pharma-ranitidine-tablets-150mg-recall-ndma-impurity-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-0794-2020
Cite this page
“Denton Pharma Ranitidine Tablets 150mg Recall: NDMA Impurity Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37510-denton-pharma-ranitidine-tablets-150mg-recall-ndma-impurity-risk. Based on FDA recall #D-0794-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0794-2020%22&limit=1).
Why it’s dangerous
The recall is due to the presence of NDMA impurity in the ranitidine tablets. NDMA is a chemical that has been linked to potential health risks, including cancer, though the risk level is considered low for short-term use. The impurity was detected during manufacturing quality control checks.
Who’s affected
People who own or use the recalled ranitidine tablets (150mg) from Denton Pharma, specifically those with the listed bottle sizes and expiration dates. Those who have been using these tablets for extended periods are at higher risk due to potential long-term health effects.
How to tell if you have this one
Check for bottles labeled 'Ranitidine Tablets, USP 150 mg' with specific counts: 4-count, 20-count, 24-count, 30-count, or 90-count. Look for the NDC codes listed: 70934-017-04, 70934-017-20, 70934-017-24, 70934-017-30, or 70934-017-90. The products were repackaged by Northwind Pharmaceuticals and have expiration dates from 2021 to 2022.
- Brand
Denton Pharma- Category
Drug
All 2 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Terminated- Distribution
Nationwide
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| D-0794-2020 | Ranitidine Tablets, USP 150 mg , a). 4 count bottle (NDC 70934-017-04), b). 20-count bottle (NDC 70934-017-20), c). 24-count bottle (NDC 70934-017-24) d). 30-count bottle (NDC 70934-017-30) e). 90-count bottle (NDC 70934-017-90), Rx Only, Repackaged by: Northwind Pharmaceuticals North Brenheim, NY 12131.; a). N102851902, Exp. 04/30/2021 b). D102851801, Exp. 04/2021 c). N102851901, Exp. 11/30/2021 N102851903, Exp. 12/31/2021 N102851906, Exp. 03/31/2022 d). N102851904, Exp. 02/28/2022 N102851905, Exp. 12/31/2021 e). C102851901, Exp. 11/30/2021 C102851902, Exp. 11/30/2021 C102851903, Exp. 11/30/2021 C102851904, Exp. 05/31/2021 C102851905, Exp. 02/28/2022 C102851906, Exp. 02/28/2022 C102851907, Exp. 03/31/2022 | 1,341 bottles |
| D-0795-2020 | Ranitidine Tablets, USP 300 mg a). 15-count bottles (NDC 70934-287-15), b). 90-count bottles (NDC 70934-287-90), Rx Only, Repackaged by: Northwind Pharmaceuticals North Brenheim, NY 12131; a). N106851901, Exp. 11/30/2021 N106851902, Exp. 10/31/2021 b). C106851901, Exp. 11/30/2021 C106851902 Exp. 10/31/2021 C106851903 Exp. 02/28/2022 C106851904 Exp. 11/30/2021 C106851905 Exp. 05/31/2022 | 467 bottles |
What to do — step by step
Check Product Labels
Look for the product name, bottle size, and expiration date on the label to confirm if it matches the recalled items.
Stop Using Recalled Products
If you have the recalled ranitidine tablets, stop using them immediately and contact Denton Pharma for further instructions.
Questions people ask
Why is this product being recalled?
The recall is due to the presence of NDMA impurity detected during manufacturing quality control checks.
What is the risk of using these tablets?
The NDMA impurity has been linked to potential health risks, including cancer, but the risk level is considered low for short-term use.
How can I check if I have the recalled product?
Check for bottles labeled 'Ranitidine Tablets, USP 150 mg' with specific counts (4-count, 20-count, 24-count, 30-count, or 90-count) and the listed NDC codes.
Contact Denton Pharma
We’ve drafted a message you can send Denton Pharma to request your refund or repair — edit it as you like.
Subject: Recall D-0794-2020 — Denton Pharma Denton Pharma Hello, I own a Denton Pharma that is covered by recall D-0794-2020 from Denton Pharma. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0794-2020 (December 20, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0794-2020 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.